Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy

Venkatesh K. Rudrapatna, Kimberly Morley, Kenneth M. Boucher, Andrew S. Pierson, Christian T. Shull, James P. Kushner, Paul J. Shami

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences